These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32830604)

  • 1. Effect of Visit Frequency of Pharmacist-Led Diabetes Medication Management Program.
    Frederick A; Juan J; Ivy D; Maldonado YM
    J Pharm Pract; 2022 Feb; 35(1):70-74. PubMed ID: 32830604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoeconomic analysis of the diabetes initiative program: a pharmacist-physician collaborative care model.
    Franklin BE; Farland MZ; Thomas J; McFarland MS; Ray SM; Byrd DC
    Ann Pharmacother; 2013 Dec; 47(12):1627-34. PubMed ID: 24259610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists' impact on improving outcomes in patients with type 2 diabetes mellitus.
    Pepper MJ; Mallory N; Coker TN; Chaki A; Sando KR
    Diabetes Educ; 2012; 38(3):409-16. PubMed ID: 22523190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus.
    McFarland M; Davis K; Wallace J; Wan J; Cassidy R; Morgan T; Venugopal D
    Pharmacotherapy; 2012 May; 32(5):420-6. PubMed ID: 22488512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Addition of Pharmacist Management to a Medication Assistance Program in Patients with Hypertension and Diabetes Resistant to Usual Care.
    Smith AM; Hamann GL; Campbell JD; Sprabery LR
    J Pharm Pract; 2022 Aug; 35(4):606-611. PubMed ID: 33739190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation and Clinical Outcomes of an Employer-Sponsored, Pharmacist-Provided Medication Therapy Management Program.
    Theising KM; Fritschle TL; Scholfield AM; Hicks EL; Schymik ML
    Pharmacotherapy; 2015 Nov; 35(11):e159-63. PubMed ID: 26598100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Impact of a Pharmacist-Led Telehealth Clinic on Diabetes-Related Goals of Therapy in a Veteran Population.
    Maxwell LG; McFarland MS; Baker JW; Cassidy RF
    Pharmacotherapy; 2016 Mar; 36(3):348-56. PubMed ID: 26877253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist impact on health outcomes in a homeless population.
    Bahrami S; Chang C; Alvarez KS; Lutek K; Nguyen S; Hegde A
    J Am Pharm Assoc (2003); 2020; 60(3):485-490. PubMed ID: 31901441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes.
    Ulrich H; Bowen M
    J Am Pharm Assoc (2003); 2021; 61(6):e76-e82. PubMed ID: 34154906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of a pharmacist + health coach chronic disease management program in a rural free clinic.
    Hurst H; Dunn S; Fuji KT; Gilmore J; Wilt S; Webster S; Parikh P
    J Am Pharm Assoc (2003); 2021; 61(4):442-449. PubMed ID: 33775539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of medication therapy management on underserved, primarily Hispanic patients with diabetes.
    Congdon HB; Dowling TC; Cheng I; Truong HA
    Ann Pharmacother; 2013 May; 47(5):665-70. PubMed ID: 23585643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Clinical Pharmacist Intervention on Hemoglobin A1C Reduction in Veteran Patients With Type 2 Diabetes in a Rural Setting.
    Sullivan J; Jett BP; Cradick M; Zuber J
    Ann Pharmacother; 2016 Dec; 50(12):1023-1027. PubMed ID: 27497068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effectiveness and cost savings in diabetes care, supported by pharmacist counselling.
    Rodriguez de Bittner M; Chirikov VV; Breunig IM; Zaghab RW; Shaya FT
    J Am Pharm Assoc (2003); 2017; 57(1):102-108.e4. PubMed ID: 27769877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of pharmaceutical care on improving outcomes in patients with type 2 diabetes mellitus from China: a pre- and postintervention study.
    Xin C; Ge X; Yang X; Lin M; Jiang C; Xia Z
    Int J Clin Pharm; 2014 Oct; 36(5):963-8. PubMed ID: 24993458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in Clinical Outcomes and Access to Care With Pharmacist-Led Chronic Care Management Services at a Rural Family Medicine Clinic.
    Tenpas AS; Vascimini A; Westwood G; Morris E; Dietrich E; DeRemer C
    J Pharm Pract; 2023 Dec; 36(6):1392-1396. PubMed ID: 35938485
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility.
    Wallgren S; Berry-Cabán CS; Bowers L
    Ann Pharmacother; 2012 Mar; 46(3):353-7. PubMed ID: 22395249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the Effect of Pharmacist Care on Diabetes-Related Outcomes in a Rural Outpatient Clinic: A Retrospective Case-Control Study.
    Moreau C; Sando KR; Zambrano DH
    Ann Pharmacother; 2017 Jun; 51(6):473-478. PubMed ID: 28064508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a Pharmacist-Led Group Diabetes Class.
    Lakey H; Boehmer K; Johnson C
    J Pharm Pract; 2022 Feb; 35(1):54-56. PubMed ID: 32783491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
    Morello CM; Nguyen T; Tao L; Hirsch JD
    Ann Pharmacother; 2020 Sep; 54(9):858-865. PubMed ID: 32100551
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice.
    Kiel PJ; McCord AD
    Ann Pharmacother; 2005 Nov; 39(11):1828-32. PubMed ID: 16219894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.